🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
211.40
-1.30 (-0.61%)
Nov 20, 2026, 11:00 AM CET

Zealand Pharma Revenue

Zealand Pharma had revenue of 4.00M DKK in the quarter ending September 30, 2026, a decrease of -92.00%. This brings the company's total for the last twelve months to 4.60B, down -49.78% year-over-year. In the year 2025, Zealand Pharma had annual revenue of 9.21B with 14,598.86% growth. That makes Zealand Pharma the 9,576th largest company in the world by revenue and 42nd in Denmark.

Revenue (ttm)
4.60B
Revenue Growth
-49.78%
P/S Ratio
3.09
Revenue / Employee
7.60M
Employees
605
Market Cap
14.13B

Revenue Chart

Revenue by Geography

  • Switzerland 9.18B 99.6%
  • Denmark 34.90M 0.4%
Fiscal year ended Dec 31, 2025 See the full Zealand Pharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.21B9.15B14,598.86%
Dec 31, 202462.69M-280.10M-81.71%
Dec 31, 2023342.79M238.80M229.65%
Dec 31, 2022103.99M-4.56M-4.20%
Dec 31, 2021108.55M-83.46M-43.47%
Dec 31, 2020192.00M150.67M364.52%
Dec 31, 201941.33M3.36M8.84%
Dec 31, 201837.98M-98.35M-72.14%
Dec 31, 2017136.32M-94.54M-40.95%
Dec 31, 2016230.86M43.19M23.01%
Dec 31, 2015187.68M33.90M22.05%
Dec 31, 2014153.77M147.20M2,239.11%
Dec 31, 20136.57M-216.99M-97.06%
Dec 31, 2012223.57M81.28M57.13%
Dec 31, 2011142.28M54.93M62.88%
Dec 31, 201087.36M62.04M245.03%
Dec 31, 200925.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Novo Nordisk333.65B
Coloplast28.94B
Genmab28.27B
Demant24.63B
GN Store Nord16.52B
ALK-Abelló7.06B
Embla Medical6.56B
Ambu A/S6.47B
Revenue Rankings